{"title":"Billionaire Sacklers granted lifetime legal immunity in opioid settlement","link":"https://arstechnica.com/?p=1791587","date":1630600501000,"content":"<div>\n<figure><img src=\"https://cdn.arstechnica.net/wp-content/uploads/2021/09/GettyImages-1333269010-800x533.jpeg\" /><p><a href=\"https://cdn.arstechnica.net/wp-content/uploads/2021/09/GettyImages-1333269010.jpeg\">Enlarge</a> <span>/</span> Friends and family members of people who have died during the opioid epidemic protest against a bankruptcy deal with Purdue Pharmaceuticals that allows the Sackler family to avoid criminal prosecution and to keep billions of dollars in private wealth, on August 9, 2021, outside the Federal courthouse in White Plains, New York.  (credit: <a href=\"https://www.gettyimages.com/detail/news-photo/friends-and-family-members-of-people-who-have-died-during-news-photo/1333269010?adppopup=true\">Getty |  Andrew Lichtenstein</a>)</p>  </figure><div><a name=\"page-1\"></a></div>\n<p>A federal bankruptcy judge on Wednesday approved a $4.5 billion opioid settlement that provides sweeping lifetime legal immunity for the billionaire Sackler family behind Purdue Pharma.</p>\n<p>“This is a bitter result,” Federal Judge Robert Drain said Wednesday in a lengthy explanation of his approval of the settlement. \"I believe that at least some of the Sackler parties also have liability for those [opioid] claims… I would have expected a higher settlement.”</p>\n<p>The Sacklers owned and were largely directing Purdue Pharma in the late 1990s when the company allegedly began aggressively and deceptively selling its highly addictive opioid painkiller, OxyContin. Purdue, which has twice pled guilty for wrongdoing in marketing OxyContin, is widely seen as sparking the nationwide epidemic of opioid addiction and overdoses. The opioid crisis has killed nearly <a href=\"https://www.cdc.gov/opioids/data/analysis-resources.html\">500,000 people in the US in the past two decades</a>.</p></div><p><a href=\"https://arstechnica.com/?p=1791587#p3\">Read 14 remaining paragraphs</a> | <a href=\"https://arstechnica.com/?p=1791587&amp;comments=1\">Comments</a></p>","author":"Beth Mole","siteTitle":"Ars Technica","siteHash":"5b0ddf6e8923e49262a7894cfd77962733e43fbcc565a103b48373820b310636","entryHash":"28ff1db6dfe4e6d0233c8a1618f3a7559d885fbb8f9e09e0ea3eb16970081b85","category":"Tech"}